Outcome of Post-Resection Intravesical BCG and Mitomycin C Therapy on Non-Muscle Invasive High- Grade Transitional Cell Carcinoma of Urinary Bladder. Bang J Urology 2022, 24 (1), 62-71. https://doi.org/10.3329/bju.v24i1.59446.